Investing Profile

Michael Anstey

InvestorVC
Partner at Cambridge Innovation Capital
cic.vc/team/Cambridge, United Kingdom
Photo of Michael Anstey, Partner at Cambridge Innovation Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$600K - $6.0M
$3.3M
2
£225M
CompanyStageDateRound SizeTotal Raised
TRIMTECH Therapeutics
SeedMar 2025$31M
$31M
Co-investors: Hakan Goker (M Ventures (Merck)), Jeffrey Moore (MP Healthcare Venture Management), Laurence Barker (SV Health Investors)
PredictImmune
Series BJul 2019$12M
$25M
Co-investors: Alastair Kilgour (Parkwalk Advisors)